Advances in Cancer Drug Targets
Latest Publications

TOTAL DOCUMENTS

11

(FIVE YEARS 0)

H-INDEX

0

(FIVE YEARS 0)

Published By BENTHAM SCIENCE PUBLISHERS

9781681082332

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Melatonin Inhibits the Growth of DMBA-induced Mammary Tumors by Regulating Estrogen Sulfatase Enzyme

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030008 ◽

2016 ◽

pp. 181-206

Keyword(s):

Mammary Tumors ◽

Estrogen Sulfatase

Download Full-text

Neutrophil Elastase as a Target in Lung Cancer: the State of the Art

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030003 ◽

2016 ◽

pp. 3-49

Keyword(s):

Lung Cancer ◽

Neutrophil Elastase ◽

State Of The Art ◽

The State

Download Full-text

Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030007 ◽

2016 ◽

pp. 156-180

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Cell Lines ◽

Squamous Cell ◽

Carcinoma Cell ◽

Neck Squamous Cell Carcinoma ◽

Squamous Cell Carcinoma Cell ◽

Carcinoma Cell Lines

Download Full-text

Collaboration of Epithelial Mesenchymal Transition and Cancer Stem Cells: Sinister Routes for Chemoresistant Recurrent Ovarian Cancer

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030006 ◽

2016 ◽

pp. 118-155

Keyword(s):

Ovarian Cancer ◽

Stem Cells ◽

Cancer Stem Cells ◽

Epithelial Mesenchymal Transition ◽

Recurrent Ovarian Cancer ◽

Mesenchymal Transition

Download Full-text

Inhibition of Membrane Complement Inhibitor Expression (CD46, CD55, CD59) by siRNA Sensitizes Tumor Cells to Complement Attack

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030004 ◽

2016 ◽

pp. 50-77

Keyword(s):

Tumor Cells ◽

Complement Inhibitor

Download Full-text

Preface

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030001 ◽

2016 ◽

pp. i-ii

Download Full-text

List of Contributors

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030002 ◽

2016 ◽

pp. iii-v

Download Full-text

Points of Therapeutic Intervention along the Wnt Signaling Pathway in Hepatocellular Carcinoma

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030005 ◽

2016 ◽

pp. 78-117

Keyword(s):

Hepatocellular Carcinoma ◽

Wnt Signaling ◽

Signaling Pathway ◽

Therapeutic Intervention ◽

Wnt Signaling Pathway

Download Full-text

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030010 ◽

2016 ◽

pp. 245-264

Keyword(s):

Structure Activity ◽

Ras Inhibitors

Download Full-text

Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis

Advances in Cancer Drug Targets ◽

10.2174/9781681082332116030009 ◽

2016 ◽

pp. 207-244

Keyword(s):

Tumor Cell ◽

Cell Motility ◽

Mtor Signaling ◽

Invasion And Metastasis ◽

Tumor Cell Motility

Download Full-text